Company / Operating Cash Flow per Share
Protara Therapeutics, Inc. Operating Cash Flow per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.61
FY2016
5-year range
-$34.32 / -$0.40
FY2014-FY2016
Trend
-49.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-34.32 to $-0.61 over the past 2 years.
Based on SEC 10-K filings.
-0.61 in FY2016.
Improved from $-34.32 to $-0.61 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, operating cash flow per share decreased 49.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$0.61 | -49.6% |
| FY2015 | -$0.40 | +98.8% |
| FY2014 | -$34.32 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026